2Daniel G, Luglas R, Samuel J, et al. Combination immunotherapy with mluble tumor necrosis factor receptors plus interleukin-1 receptor antagonist decreases sepsis mortality[J]. Crit Care Med, 2001, 29:473-481.
3Wunder C, Eichelbrormer O, Roewer N. Are IL-6, IL-10 and PCT plasma concentrations reliable for outcome prediction in severesepsis? A comparison with APACHE III and SAPS II [J]. Inflamm Res, 2004, 53: 158-163.
